Legislative Activity

The "Protecting Our Guests During Hostilities in Ukraine Act" establishes a "Ukrainian guest status" for individuals paroled into the U.S. under the Uniting for Ukraine program, allowing them to work in the U.S. This status begins from their initial parole date and expires 120 days after the Secretary of State determines it is safe for civilians to return to Ukraine, but can be revoked by Homeland Security if the individual poses a security risk.

The Postal Processing Protection Act broadens existing protections for post offices to include any Postal Service facility involved in acceptance, processing, shipping, delivery, or distribution that supports one or more post offices. This bill amends section 404(d) of title 39, United States Code, to reflect this change.

The "Born in the USA Act" prohibits the use of government funds to implement Executive Order 14160, which sought to deny citizenship to certain children born in the United States. The bill affirms that birthright citizenship is guaranteed by the 14th Amendment of the Constitution and cannot be rescinded by executive order.

The Korematsu-Takai Civil Liberties Protection Act of 2025 amends Title 18 of the United States Code, Section 4001, to prohibit the detention of individuals in the United States based solely on protected characteristics. Protected characteristics include race, ethnicity, national origin, religion, sex, gender identity, sexual orientation, disability, and any additional characteristic the Attorney General specifies. The Attorney General cannot remove any of the characteristics already listed (race through disability).

The "Safe and Affordable Drugs from Canada Act of 2025" allows individuals to import prescription drugs from approved Canadian pharmacies under specific conditions, including a valid U.S. prescription and adherence to quality and safety standards. The imported drugs must be for personal use, up to a 90-day supply, and must match the U.S.-approved version in active ingredients, dosage, and strength. Certain types of drugs, like controlled substances and biological products, are excluded from importation. The Secretary will establish and maintain a list of approved Canadian pharmacies that meet strict criteria to ensure drug safety and quality.

The OPIOIDS Act allows the Attorney General to award grants to improve data collection and surveillance of opioid-related overdoses at the state, territorial, and local levels. It also provides grants to local law enforcement and forensic labs in high-overdose areas for training, system upgrades, and drug tracing. The Act mandates consistent data reporting standards for drug information and requires specific funding for the DEA's Fentanyl Signature Profiling Program.

Here are the high-level summaries for each title of the I CAN Act: **Title I: Removal of Barriers to Practice on Nurse Practitioners** This title aims to improve healthcare access for Medicare and Medicaid beneficiaries by expanding the scope of practice and recognition of nurse practitioners, allowing them to provide a wider range of services such as prescribing rehabilitation programs, documenting diabetic shoe needs, and overseeing care in various settings. **Title II: Removal of Barriers to Practice on Certified Registered Nurse Anesthetists** This title focuses on reducing practice barriers for Certified Registered Nurse Anesthetists (CRNAs) by allowing Medicare reimbursement for their services, updating regulations to affirm their authority, removing mandatory supervision requirements, and ensuring Medicaid coverage. **Title III: Removal of Barriers to Practice on Certified Nurse-Midwives** This title seeks to expand the role of certified nurse-midwives (CNMs) in the Medicare system by including their services in coverage, enabling them to order home health services and durable medical equipment, and standardizing qualification standards. **Title IV: Improving Federal Health Programs for All Advanced Practice Registered Nurses** This title aims to increase transparency in Medicare coverage decisions, prevent coverage limitations based on provider qualifications, and expand access to locum tenens arrangements for advanced practice registered nurses (APRNs). **Title V: Effective Date** This title sets a 90-day timeline for the implementation of the new law's provisions and authorizes the Secretary of Health and Human Services to issue temporary guidelines for a smooth transition.

The "First Rhode Island Regiment Congressional Gold Medal Act" authorizes the creation of a Congressional Gold Medal to collectively honor the First Rhode Island Regiment for their heroic service during the Revolutionary War. This regiment, one of the first racially integrated units in American history, was composed of African American, Indigenous, and mixed-race soldiers. The gold medal will be presented to the Rhode Island State Library for public display and research, with the hope that it will also be exhibited at other locations associated with the Regiment. The Act also allows for the creation and sale of bronze duplicates of the medal to support the United States Mint Public Enterprise Fund.

This bill officially designates the mountain located at 630412 N, by 1510018 W in Alaska as Denali. It mandates that all U.S. laws, maps, regulations, and records must recognize and refer to the mountain as Denali.

The Stop Antiabortion Disinformation (SAD) Act aims to prevent deceptive advertising related to reproductive health services, particularly concerning abortion and contraception. It empowers the Federal Trade Commission (FTC) to regulate and enforce this prohibition, including the ability to bring civil actions against violators, with significant financial penalties for non-compliance. The Act also mandates regular reporting to Congress on enforcement activities.

The "Capping Prescription Costs Act of 2025" aims to lower prescription drug costs by setting annual cost-sharing limits. Starting in 2026, individual out-of-pocket expenses for prescription drugs will be capped at $2,000, and family expenses at $4,000 under qualified health plans. These limits will be adjusted annually based on the consumer price index. The act also ensures that group health plans adhere to cost-sharing limits set by the Affordable Care Act.

The Pharmacy Benefit Manager Transparency Act of 2025 aims to regulate pharmacy benefit managers (PBMs) by prohibiting unfair pricing practices, requiring transparency in pricing and reporting, and protecting whistleblowers who report violations. It mandates PBMs to disclose drug costs, fees, and payments received from drug manufacturers, and it empowers the FTC and state attorneys general to enforce the Act. The Act also requires reports and studies on PBM practices to promote competition and lower drug costs. This law does not override existing state laws.

This resolution expresses the Senate's opposition to deploying U.S. military assets or personnel to "take over" Gaza. It emphasizes the importance of Palestinian self-determination, warns against the negative consequences of U.S. control over Gaza, and highlights public and congressional concerns about unauthorized military action and financial expenditure. The resolution underscores that the U.S. should not use its military or resources to control Gaza.

The "Fair Funding for Rural Hospitals Act" amends the Social Security Act to set a minimum Medicaid Disproportionate Share Hospital (DSH) allotment for each state, ensuring more stable funding for hospitals that serve a large number of low-income patients. Starting in 2025, every state will receive a DSH allotment of no less than $20,000,000, adjusted for inflation in later years, regardless of other calculations or required reductions. This aims to provide financial stability to rural hospitals.

The "Foreign Assistance Accountability and Oversight Act" establishes a Director of Foreign Assistance within the State Department to optimize the impact of foreign assistance by aligning resources with foreign policy goals, measuring effectiveness, and promoting transparency. This director will lead strategic planning, budget processes, and program evaluations, ensuring resources are obligated in a timely manner. The act also affirms USAID's status as an independent agency and emphasizes the importance of congressional oversight in foreign assistance management.

The "Carried Interest Fairness Act of 2025" changes the tax treatment of certain partnership interests, especially those related to investment management services. It reclassifies certain capital gains as ordinary income for partners providing these services, modifies the valuation and tax implications of partnership interests transferred for services, and introduces stricter rules to prevent tax avoidance. This act aims to ensure that income derived from investment management is taxed at ordinary income rates rather than more favorable capital gains rates. It also includes provisions addressing qualified dividend income, gains from qualified small business stock, and the treatment of income from special purpose acquisition companies.

The New Markets Tax Credit Extension Act of 2025 permanently extends the New Markets Tax Credit, originally set to expire after 2025, to encourage investment in low-income communities. The bill also adjusts the credit amount for inflation after 2025 and provides alternative minimum tax relief for credits on qualified equity investments made after December 31, 2024. These changes aim to incentivize ongoing investment in economically distressed areas.

The "Protecting Sensitive Locations Act" amends the Immigration and Nationality Act to limit immigration enforcement actions within 1,000 feet of sensitive locations like schools and places of worship, requiring supervisor consultation and discreet conduct. Exceptions are allowed only in cases of national security or public safety threats or medical emergencies. The Act mandates annual training, detailed reporting of enforcement actions, and evidence suppression for violations, enhancing oversight and accountability in immigration enforcement.

The "End Double Taxation of Successful Consumer Claims Act" allows taxpayers to deduct attorney fees and court costs related to claims of consumer protection violations. This deduction applies to a broad range of violations under federal, state, and local laws, including those related to real estate, lending, credit, debt collection, product safety, and more. This change applies to attorney fees and court costs paid in taxable years ending after the enactment date of this Act, for judgments or settlements occurring in those taxable years.

The "Responsibility in Drug Advertising Act of 2025" amends the Federal Food, Drug, and Cosmetic Act to regulate direct-to-consumer advertising of prescription drugs. It prohibits advertising of newly approved drugs for the first three years and allows the Secretary to extend the prohibition if significant adverse health effects are identified. The Secretary of Health and Human Services is required to revise drug advertisement regulations within one year to implement these changes.